Cytokines and depression in cancer patients and caregivers

References

• MohamedSJohnsonGRChenPEffect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trialJAMA2017318213214528697253
   PubMed Web of Science ®Google Scholar
• LiMKennedyEBByrneNSystematic review and meta-analysis of collaborative care interventions for depression in patients with cancerPsychooncology201726557358727643388
   PubMed Web of Science ®Google Scholar
• LiMSoczynskaJKKennedySHInflammatory biomarkers in depression. An opportunity for novel therapeutic interventionsCurr Psychiatry Rep201113531632021671010
   PubMed Web of Science ®Google Scholar
• LowCABovbjergDHDepressive symptoms in patients with cancer. Does cortisol keep cytokines from singing the blues?Psychosom Med201476424825124804878
   PubMed Web of Science ®Google Scholar
• MillerAHMaleticVRaisonCLInflammation and its discontents: the role of cytokines in the pathophysiology of major depressionBiol Psychiatry200965973274119150053
   PubMed Web of Science ®Google Scholar
• DantzerRMeagherMWCleelandCSTranslational approaches to treatment-induced symptoms in cancer patientsNat Rev Clin Oncol20129741442622641361
   PubMed Web of Science ®Google Scholar
• WuSMYangHCThayerJFAndersonBLAssociation of the physiological stress response with depressive symptoms in patients with breast cancerPsychosom Med201476425225624804879
   PubMed Web of Science ®Google Scholar
• MillerAHAncoli-IsraelSBowerJECapuronLIrwinMRNeuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancerJ Clin Oncol200826697198218281672
   PubMed Web of Science ®Google Scholar
• CuthbertBNThe RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathologyWorld Psychiatry2014131283524497240
   PubMed Web of Science ®Google Scholar
• EuteneuerFSchwarzMJDannehlKHartungAWestermannSRiefWIncreased soluble interleukin-2 receptor levels are related to somatic but not to cognitive-affective features in major depressionBrain Behav Immun20122681244124822728327
   PubMed Web of Science ®Google Scholar
• DuivisHEVogelzangsNKupperNde JongePPenninxBWDifferential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA)Psychoneuroendocrinology20133891573158523399050
   PubMed Web of Science ®Google Scholar
• DannehlKRiefWSchwarzMJThe predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depressionNeuropsychiatr DisTreat20141011911197
   Web of Science ®Google Scholar
• BraunMMikulincerMRydallAWalshARodinGHidden morbidity in cancer: spouse caregiversJ Clin Oncol200725304829483417947732
   PubMed Web of Science ®Google Scholar
• RohlederNMarinTJMaRMillerGEBiologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathwaysJ Clin Oncol200927182909291519433690
   PubMed Web of Science ®Google Scholar
• LiMKouzminaEMcCuskerMPro- and anti-inflammatory cytokine associations with major depression in cancer patientsPsychooncology Epub2016111510.1002/pon.4316
   Web of Science ®Google Scholar
• SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859suppl 202233
   PubMed Web of Science ®Google Scholar
• FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical Interview for DSM-IV Axis I Disorders Clinician Version (SCID-CV)Washington, DCAmerican Psychiatric Press. Inc1996
   Google Scholar
• TabuseHKalaliAAzumaHThe new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after trainingPsychiatry Res20071531616717445908
   PubMed Web of Science ®Google Scholar
• WilliamsJBKobakKABechPThe GRID-HAMD: standardization of the Hamilton Depression Rating ScaleInt Clin Psychopharmacol200823312012918408526
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• ShaferABMeta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and ZungJ Clin Psychol200662112314616287149
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• O’ConnorMFBowerJEChoHJTo assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markersBrain Behav Immun200923788789719389469
   PubMed Web of Science ®Google Scholar
• ChenYJiangTChenPEmerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cellsPsychiatry Res2011188222423021129782
   PubMed Web of Science ®Google Scholar
• DowlatiYHerrmannNSwardfagerWA meta-analysis of cytokines in major depressionBiol Psychiatry201067544645720015486
   PubMed Web of Science ®Google Scholar
• LiuYHoRCMakAInterleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regressionJ Affect Disord2012139323023921872339
   PubMed Web of Science ®Google Scholar
• FitzgeraldPLoCLiMGaglieseLZimmermanCRodinGThe relationship between depression and physical symptom burden in advanced cancerBMJ Support Palliat Care201554381388
   PubMed Web of Science ®Google Scholar
• MitchellAJLordKSymondsPWhich symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptomsJ Affect Disord20121381–213714822310033
   PubMed Web of Science ®Google Scholar
• MillsKHInduction, function and regulation of IL-17-producing T cellsEur J Immunol200838102636264918958872
   PubMed Web of Science ®Google Scholar
• NauglerWEKarinMThe wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends Mol Med200814310911918261959
   PubMed Web of Science ®Google Scholar
• LutgendorfSKWeinribAZPenedoFInterleukin-6, cortisol, and depressive symptoms in ovarian cancer patientsJ Clin Oncol200826294820482718779606
   PubMed Web of Science ®Google Scholar
• InagakiMAkechiTOkuyamaTAssociations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patientsSupport Care Cancer20132182097210623446881
   PubMed Web of Science ®Google Scholar
• BreitbartWRosenfeldBTobiasKDepression, cytokines, and pancreatic cancerPsychooncology201423333934524136882
   PubMed Web of Science ®Google Scholar
• KopfMBachmannMFMarslandBJAverting inflammation by targeting the cytokine environmentNat Rev Drug Discov20109970371820811382
   PubMed Web of Science ®Google Scholar
• MaesMBerkMGoelerLDepression and sickness behaviour are Janus-faced responses to shared inflammatory pathwaysBMC Med2012106622747645
   PubMed Web of Science ®Google Scholar
• Kopschina FeltesPDoorduinJKleinHCAnti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapyJ Psychopharmacol20173191149116528653857
   PubMed Web of Science ®Google Scholar
• SchmidtFMKirkbyKCLichtblauNInflammation and immune regulation as potential drug targets in antidepressant treatmentCur Neurophamacol2016147674687
   Web of Science ®Google Scholar
• KappelmannNLewisGDantzerRJonesPBKhandakerGMAntidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of chronic inflammatory conditions. Mol PsychiatryEpub2016101819
   Google Scholar
• HannestadJDellaGioiaNBlochMThe effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysisNeuropsychopharmacology201136122452245921796103
   PubMed Web of Science ®Google Scholar
• RaisonCLRutherfordREWoolwineBJA randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkersJAMA Psychiatry2013701314122945416
   PubMed Web of Science ®Google Scholar